Does Amitriptyline Cause More Sexual Side Effects Than SSRIs?
No, amitriptyline causes significantly fewer sexual side effects than SSRIs. The evidence consistently shows that SSRIs have substantially higher rates of sexual dysfunction compared to tricyclic antidepressants like amitriptyline.
Sexual Dysfunction Rates
The data clearly demonstrates a hierarchy of sexual side effects:
SSRIs have the highest rates: Sexual dysfunction occurs in 58-73% of patients taking SSRIs 1, 2. Specifically:
Amitriptyline has much lower rates: Only 5.7% overall, with 11.9% in men and 1.7% in women 3. This represents approximately a 6-fold lower risk compared to SSRIs.
Gender Differences and Clinical Patterns
Men experience sexual dysfunction more frequently than women with amitriptyline (6-fold higher in men) 3. The dysfunction primarily affects:
- In men: Arousal and libido more than orgasm/ejaculation
- In women: Mainly libido 3
Importantly, amitriptyline-associated sexual dysfunction gradually decreases over 8 weeks of treatment 3, whereas SSRI-related dysfunction tends to persist throughout treatment 4.
Mechanism and Clinical Context
While amitriptyline does list "increased or decreased libido" and "impotence" as potential adverse effects 5, the clinical reality is that its anticholinergic and antihistaminic properties do not produce the same degree of sexual dysfunction as the potent serotonergic effects of SSRIs 6. SSRIs cause sexual dysfunction through serotonergic inhibition of the sexual response 7, which is a more direct and consistent mechanism.
Important Caveats
- Sexual dysfunction with amitriptyline occurs predominantly in depressive patients (6.9%) compared to non-depressive patients (0.8%) 3
- The presence of insomnia, somnolence, or nausea during amitriptyline treatment can predict sexual dysfunction 3
- Among second-generation antidepressants, paroxetine specifically has the highest rates of sexual dysfunction even compared to other SSRIs 1
Clinical Bottom Line
When sexual function is a priority concern, amitriptyline represents a significantly better choice than SSRIs from a sexual side effect perspective. However, the decision must also weigh amitriptyline's other side effects (anticholinergic effects, cardiac risks, weight gain) against the patient's overall clinical picture 5. If avoiding sexual dysfunction is paramount and depression treatment is needed, consider alternatives like bupropion, mirtazapine, or moclobemide, which have even lower rates (3.9-24.4%) than amitriptyline 2.